Skip to main content

BioTelemetry, Inc. Names Dr. Andrei Stoica Chief Technology Officer

Written by Customer Service on . Posted in Public Companies.

MALVERN, Pa., April 07, 2020 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that Dr. Andrei Stoica has been named Chief Technology Officer of the company.  Dr. Stoica will lead the company’s global technology and product development operations, reporting to Joseph H. Capper, President and Chief Executive Officer.
“We are delighted to welcome Andrei to our BioTelemetry team during this transformational time of growth and innovation,” said Joseph H. Capper, President and Chief Executive Officer of BioTelemetry.  “His extensive expertise in enterprise technology solutions, including cloud platforms, information security, and software and product development, will be instrumental as we continue to create best-in-class solutions across our product and service offerings.”   Since 2006, Dr. Stoica held various leadership positions at IQVIA, most recently serving as its SVP, IT Systems Development, leading the development of the global data and AI/ML cloud platform.  His appointments prior to IQVIA include information technology positions in the health IT industry as well as research and teaching positions in academia.  Dr. Stoica holds a Ph.D. in Computer Science and Engineering from the University of South Carolina.  He has served on multiple committees and authored numerous papers, and has been recognized and awarded for his use of technology innovation to evolve enterprise IT.“This is an exciting time for BioTelemetry, and I am looking forward to working with a team that shares my passion for leveraging technology and innovation to address today’s healthcare challenges and save lives,” said Dr. Stoica.  “BioTelemetry is an established leader in connected health, and we are uniquely positioned to offer a continuum of solutions that truly makes a difference for our patients and customers.  Our IoT cloud platform and clinical subject matter expertise already provides a differentiating capability to aid physicians in making informed decisions about patient treatments, and our platforms will constantly improve powered by AI/ML technologies.”About BioTelemetryBioTelemetry, Inc. is the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care.  We provide remote cardiac monitoring, centralized core lab services for clinical trials, remote blood glucose monitoring, and original equipment manufacturing that serves both healthcare and clinical research customers.  More information can be found at www.gobio.com.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.